Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sanofi's Experimental Oral Multiple Sclerosis Treatment Reduces Relapses
Sanofi's Experimental Oral Multiple Sclerosis Treatment Reduces Relapses
Sanofi's Experimental Oral Multiple Sclerosis Treatment Reduces Relapses
Submitted by
admin
on August 30, 2010 - 11:18am
Source:
Bloomberg
News Tags:
Sanofi
MS
teriflunomide
Merck KGaA
multiple sclerosis
Novartis
Headline:
Sanofi's Experimental Oral Multiple Sclerosis Treatment Reduces Relapses
Do Not Allow Advertisers to Use My Personal information
